Exploring Bacterial Heparinase II Activities with Defined Substrates

被引:15
作者
Bohlmann, Lisa [1 ]
Chang, Chih-Wei [1 ]
Beacham, Ifor [1 ]
von Itzstein, Mark [1 ]
机构
[1] Griffith Univ, Inst Glyc, Nathan, Qld 4222, Australia
关键词
enzyme catalysis; heparinase; heparan sulfate; heparin; natural products; substrate specificity; MOLECULAR-WEIGHT HEPARINS; FLAVOBACTERIUM-HEPARINUM; POLYSACCHARIDE LYASES; HEPARITINASE-I; GLYCOSAMINOGLYCANS; SPECIFICITY; OLIGOSACCHARIDES; DEPOLYMERIZATION; CANCER;
D O I
10.1002/cbic.201500081
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Bacterial heparinases that cleave heparan sulfate (HS) and heparin are widely used to generate low-molecular-weight heparins (LMWHs) and to structurally and functionally characterise heparin and HS biomolecules. We provide novel insights into the substrate specificity of heparinase II from two different bacteria: Pedobacter heparinus (formerly Flavobacterium heparinum) and Bacteroides eggerthii. The activity towards various well-defined HS oligosaccharides was investigated by H-1 NMR spectroscopy; this revealed distinct specificities for the two heparinases. Heparinase II from P. heparinus appears to be more active and displays a broader substrate specificity than B. eggerthii heparinase II. Furthermore, HS di- and tetrasaccharides inhibited B. eggerthii heparinase II activity. A better understanding of heparinase substrate specificity will contribute to the production of homogenous LMWHs, provide better characterisation of heparin and HS and assist therapeutic applications.
引用
收藏
页码:1205 / 1211
页数:7
相关论文
共 28 条
[1]
Characterization of a Bacteroides species from human intestine that degrades glycosaminoglycans [J].
Ahn, MY ;
Shin, KH ;
Kim, DH ;
Jung, EA ;
Toida, T ;
Linhardt, RJ ;
Kim, YS .
CANADIAN JOURNAL OF MICROBIOLOGY, 1998, 44 (05) :423-429
[2]
BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356
[3]
SUBSTRATE-SPECIFICITY OF THE HEPARIN LYASES FROM FLAVOBACTERIUM-HEPARINUM [J].
DESAI, UR ;
WANG, HM ;
LINHARDT, RJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 306 (02) :461-468
[4]
SPECIFICITY STUDIES ON THE HEPARIN LYASES FROM FLAVOBACTERIUM-HEPARINUM [J].
DESAI, UR ;
WANG, HM ;
LINHARDT, RJ .
BIOCHEMISTRY, 1993, 32 (32) :8140-8145
[5]
HEPARINASE PRODUCTION BY FLAVOBACTERIUM-HEPARINUM [J].
GALLIHER, PM ;
COONEY, CL ;
LANGER, R ;
LINHARDT, RJ .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1981, 41 (02) :360-365
[6]
Heparin octasaccharides inhibit angiogenesis in vivo [J].
Hasan, J ;
Shnyder, SD ;
Clamp, AR ;
McGown, AT ;
Bicknell, R ;
Presta, M ;
Bibby, M ;
Double, J ;
Craig, S ;
Leeming, D ;
Stevenson, K ;
Gallagher, JT ;
Jayson, GC .
CLINICAL CANCER RESEARCH, 2005, 11 (22) :8172-8179
[7]
SR 90107A Org 31540, a novel anti-factor Xa antithrombotic agent [J].
Herbert, JM ;
Petitou, M ;
Lormeau, JC ;
Cariou, R ;
Necciari, J ;
Magnani, HN ;
Zandberg, P ;
vanAmsterdam, RGM ;
vanBoeckel, CAA ;
Meuleman, DG .
CARDIOVASCULAR DRUG REVIEWS, 1997, 15 (01) :1-26
[8]
A dose-determining trial of heparinase-I (Neutralase™) for heparin neutralization in coronary artery surgery [J].
Heres, EK ;
Horrow, JC ;
Gravlee, GP ;
Tardiff, BE ;
Luber, J ;
Schneider, J ;
Barragry, T ;
Broughton, R .
ANESTHESIA AND ANALGESIA, 2001, 93 (06) :1446-1452
[9]
De Novo Sequencing of Heparan Sulfate Oligosaccharides by Electron-Activated Dissociation [J].
Huang, Yu ;
Yu, Xiang ;
Mao, Yang ;
Costello, Catherine E. ;
Zaia, Joseph ;
Lin, Cheng .
ANALYTICAL CHEMISTRY, 2013, 85 (24) :11979-11986
[10]
Cloning, expression and characterization of acharan sulfate-degrading heparin lyase II from Bacteroides stercoris HJ-15 [J].
Hyun, Y. -J. ;
Lee, K. -S. ;
Kim, D. -H. .
JOURNAL OF APPLIED MICROBIOLOGY, 2010, 108 (01) :226-235